This is a StreetInsider.com Premium Only Page

(OVID) – Trader Talk

Mar 22, 2022 12:30 PM Ovid Therapeutics (OVID) granted US patent number 11,278,529 titled - Patent Grants

Mar 3, 2021 07:14 AM Ovid Therapeutics (OVID) Climbs 80% Following Pact with Takeda on Soticlestat

Jul 16, 2020 07:14 AM

Jul 15, 2020 07:40 AM

Mar 13, 2020 06:50 AM

Sep 4, 2019 08:57 AM

Jun 12, 2017 04:06 PM